Form 8-K GW PHARMACEUTICALS PLC For: May 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
GW Pharma (GWPH) PT Raised to $200 at Cowen
May 7, 2019 6:43 AM EDTCowen analyst Phil Nadeau raised the price target on GW Pharma (NASDAQ: GWPH) to $200.00 (from $175.00) while maintaining a Outperform rating following results.
The analyst commented, "GW reported $33.5MM in Epidiolex revenue during its first full quarter on the market, well ahead of consensus... More
GW Pharma (GWPH) PT Raised to $229 at Cantor Fitzgerald
May 7, 2019 6:42 AM EDTCantor Fitzgerald analyst Elemer Piros raised the price target on GW Pharma (NASDAQ: GWPH) to $229.00 (from $196.00) while maintaining a Overweight rating following Q1 results.
Piros commented, "The company reported the first full quarter of EPIDIOLEX revenues of $33.5 million. Additionally, GWPH reported positive... More
